By Richard B. Gibson As many will remember, in 2018, now infamous Chinese researcher He Jiankui announced on YouTube that, using CRISPR/Cas9, he had been (jointly) responsible for creating gene-edited twins called Lulu & Nana. He and his team’s purported aim was to engineer the twins to be resistant to HIV infection. Two days after […]
Category: Genome editing
Mind the anticipatory gap: factoring future moral change into the governance of human genome editing
By John Danaher. Human genome editing is a potentially transformative emerging technology. Current clinical trials of CRISPR, for example, suggest it can be used as a therapeutic to treat a wide range of hereditary and acquired diseases. More speculatively, it could also be used as an enhancer, improving the capacities of generally normal or healthy […]